剂泰科技-P(07666)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

07666 剂泰科技-P

已收盘 05-28 16:08:30

16.130

-1.140

-6.60%

最高17.950	最低16.020	成交量193.85万
今开17.360	昨收17.270	日振幅11.18%
总市值185.90亿	流通市值169.84亿	总股本11.53亿
成交额3,226万	换手率0.18%	流通股本10.53亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"07666","market":"HK","secType":"STK","nameCN":"剂泰科技-P","latestPrice":16.13,"timestamp":1779955710137,"preClose":17.27,"halted":0,"volume":1938500,"delay":0,"changeRate":-0.06601042269832082,"floatShares":1052926111,"shares":1152513850,"eps":0,"marketStatus":"已收盘","change":-1.14,"latestTime":"05-28 16:08:30","open":17.36,"high":17.95,"low":16.02,"amount":32259443,"amplitude":0.111754,"askPrice":16.18,"askSize":500,"bidPrice":16.13,"bidSize":3000,"shortable":0,"etf":0,"ttmEps":-0.376,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1780018200000},"marketStatusCode":5,"adr":0,"listingDate":1778601600000,"exchange":"SEHK","adjPreClose":17.27,"openAndCloseTimeList":[[1779931800000,1779940800000],[1779944400000,1779955200000]],"volumeRatio":0.286086,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/07666","defaultTab":"news","newsList":[{"id":"1158694986","title":"异动解读 | 剂泰科技-P盘中大跌5.5%，IPO后持续回调新股热度加速消退","url":"https://stock-news.laohu8.com/highlight/detail?id=1158694986","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158694986?lang=zh_cn&edition=full","pubTime":"2026-05-28 11:46","pubTimestamp":1779940011,"startTime":"0","endTime":"0","summary":"剂泰科技-P今日盘中大跌5.50%，引发市场关注。消息面上，剂泰科技作为全球AI药物递送第一股于5月13日登陆港交所，IPO发售价为10.50港元，上市首日曾大涨173%。然而，自上市以来，该股已连续多个交易日回调，较首日高点回撤显著。公司目前尚处于商业化早期阶段，过去三年累计亏损约15亿元人民币，营收波动较大，业绩增长前景仍需时间验证。此外，部分国际配售股份未设置禁售期，上市后持续面临获利了结压力。尽管公司近日发布了AiProtein平台及宣布与Deerfield达成战略联盟等利好消息，但新股上市初期的市场热度正在加速消退，导致股价承压回落态势延续。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136372381","title":"异动解读｜剂泰科技-P盘中下跌5.21%，IPO后持续回调新股热度加速消退","url":"https://stock-news.laohu8.com/highlight/detail?id=1136372381","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136372381?lang=zh_cn&edition=full","pubTime":"2026-05-28 11:42","pubTimestamp":1779939749,"startTime":"0","endTime":"0","summary":"5月28日，剂泰科技-P盘中下跌5.21%，报16.37港元，成交额1787.22万港元。该股自5月13日上市首日大涨173%后已连续多个交易日回调，较首日高点回撤显著。消息面上，剂泰科技作为全球AI药物递送第一股于5月13日登陆港交所，IPO发售价10.50港元。此外，部分国际配售股份未设置禁售期，上市后持续面临获利了结压力。尽管公司近日发布AiProtein平台及宣布与Deerfield达成战略联盟等利好，但新股上市初期市场热度加速消退，股价承压回落态势延续。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638658966","title":"Deerfield在中国生科公司首个战略联盟，与剂泰科技（07666）共推AI驱动蛋白药物与体内免疫疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=2638658966","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638658966?lang=zh_cn&edition=full","pubTime":"2026-05-28 09:12","pubTimestamp":1779930752,"startTime":"0","endTime":"0","summary":"此次合作将整合剂泰科技在AI驱动蛋白工程、体内免疫治疗及可编程生物药领域的差异化技术，与Deerfield在转化医学、临床开发及全球合作方面的深厚产业经验。剂泰科技在全球率先探索精准体内免疫治疗，将和Deerfield共同打造极具差异化优势的创新平台，加速为全球患者开发突破性疗法。期待与剂泰科技团队展开合作，共同推进基于其自主AI平台与下一代递送技术驱动的创新治疗项目开发。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1446975.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["AIPO","AGIX","BK1161","CHAT","ARTY","07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638757191","title":"港股异动 | 剂泰科技-P(07666)盘中涨超11% 公司发布METiS AiProtein平台和抗体设计智能体AARON","url":"https://stock-news.laohu8.com/highlight/detail?id=2638757191","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638757191?lang=zh_cn&edition=full","pubTime":"2026-05-27 14:30","pubTimestamp":1779863423,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，剂泰科技-P盘中涨超11%，截至发稿，涨6.96%，报17.51港元，成交额6337.35万港元。消息面上，剂泰科技正式发布AiProtein平台以及抗体设计智能体AARON。作为剂泰科技AI纳米递送平台NanoForge驱动下的第四大核心解决方案，AiProtein与AiLNP、AiRNA和AiTEM共同完成了从蛋白设计、mRNA序列设计和LNP设计的剂泰科技“火箭+卫星”端到端研发闭环。剂泰科技将依托其全球首个AI纳米递送平台NanoForge，为沙砾生物解决新一代细胞治疗药物的递送瓶颈。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1446499.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK4585","BK1161","VXUS","07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163054533","title":"异动解读 | 剂泰科技-P盘中大涨5.01%，澄清未收到中证监补充资料要求提振信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1163054533","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163054533?lang=zh_cn&edition=full","pubTime":"2026-05-27 10:34","pubTimestamp":1779849287,"startTime":"0","endTime":"0","summary":"剂泰科技-P今日盘中大涨5.01%，引起了市场的广泛关注。消息面上，公司发布澄清公告，针对此前有媒体报道称中国证监会已向包括公司在内的38家公司发出补充资讯披露要求一事，明确表示该报道与事实不符且具有误导性，公司自取得中证监备案通知以来未收到任何要求补充资料的通知。此公告有效消除了市场因不实报道而产生的疑虑，推动了股价的修复性反弹。此前，受相关不实报道影响，公司股价曾出现显著下跌，本次澄清公告发布后，市场信心得到恢复，股价随之反弹。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"fdba71cde34847d28e9e9a8cf892204a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110110332","title":"异动解读｜剂泰科技-P盘中上涨5.07%，澄清未收到中证监补充资料要求提振信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1110110332","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110110332?lang=zh_cn&edition=full","pubTime":"2026-05-27 10:31","pubTimestamp":1779849086,"startTime":"0","endTime":"0","summary":"5月27日，剂泰科技-P盘中上涨5.07%，报17.2港元，成交额1386.45万港元。消息面上，公司于5月26日发布澄清公告，针对某些媒体报道称中国证监会已向包括公司在内的38家公司发出补充资讯披露要求一事，明确表示该报道与事实不符且具有误导性，公司自取得中证监备案通知以来未收到任何要求补充资料的通知。此前受不实报道影响，股价于5月26日盘中一度大跌逾12%，本次公告有效消除市场疑虑，股价出现修复性反弹。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638036598","title":"港股异动 | 剂泰科技-P(07666)午后转涨逾3% 澄清未收到中证监任何要求补充资料的通知","url":"https://stock-news.laohu8.com/highlight/detail?id=2638036598","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638036598?lang=zh_cn&edition=full","pubTime":"2026-05-26 13:36","pubTimestamp":1779773779,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，剂泰科技-P(07666)午后转涨逾3%，截至发稿，涨2.67%，报17.33港元，成交额6204.58万港元。消息面上，剂泰科技公告，公司近期注意到若干报导某些媒体报道称，中国证券监督管理委员会已向包括本公司在内的38家公司发出补充资讯披露要求。本公司特此澄清并强调，该媒体报道中有关本公司的资讯与事实不符且具有误导性。自取得中国证监会备案通知以来，本公司未收到中国证监会任何要求补充资料的通知。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"fdba71cde34847d28e9e9a8cf892204a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445873.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK4585","VXUS","07666","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638099560","title":"剂泰科技-P：“中国证监会要求公司在内的38家公司发出补充资讯披露要求”为不实信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2638099560","media":"南方财经网","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638099560?lang=zh_cn&edition=full","pubTime":"2026-05-26 12:37","pubTimestamp":1779770220,"startTime":"0","endTime":"0","summary":"南方财经5月26日电，剂泰科技-P公告，公司近期注意到若干报导某些媒体报道称，中国证券监督管理委员会已向包括本公司在内的38家公司发出补充资讯披露要求。本公司特此澄清并强调，该媒体报道中有关本公司的资讯与事实不符且具有误导性。自取得中国证监会备案通知以来，本公司未收到中国证监会任何要求补充资料的通知。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"fdba71cde34847d28e9e9a8cf892204a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605263749421546.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["07666","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109667203","title":"剂泰科技-P回应媒体传闻 称证监会已发出补充资料要求","url":"https://stock-news.laohu8.com/highlight/detail?id=1109667203","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109667203?lang=zh_cn&edition=full","pubTime":"2026-05-26 12:29","pubTimestamp":1779769752,"startTime":"0","endTime":"0","summary":"剂泰科技-P（股票代码：07666）发布公告，就近期部分媒体报道作出澄清。该公司表示，已注意到有媒体发布报道，声称中国证监会已向其发出补充资料要求。公司特此提醒投资者，相关信息应以官方公告为准。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116754451","title":"异动解读 | 剂泰科技-P盘中大跌12.26%，IPO后持续回调新股热度加速消退","url":"https://stock-news.laohu8.com/highlight/detail?id=1116754451","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116754451?lang=zh_cn&edition=full","pubTime":"2026-05-26 09:56","pubTimestamp":1779760599,"startTime":"0","endTime":"0","summary":"剂泰科技-P今日盘中股价大跌12.26%，引起了市场的广泛关注。消息面上，剂泰科技作为全球AI药物递送第一股于近期登陆港交所，该股自上市首日大涨后已连续多个交易日回调。公司尚处于商业化早期阶段，过去三年累计亏损约15亿元人民币，营收波动较大，业绩增长前景仍需时间验证。此外，部分国际配售股份未设置禁售期，上市后持续面临获利了结压力。随着新股上市初期市场热度加速消退，股价承压回落态势延续。剂泰科技的IPO发售价为10.50港元，上市后股价经历了显著波动。此次盘中大跌是市场对其估值、基本面以及新股热度退潮后的正常调整反应。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164371949","title":"异动解读｜剂泰科技-P盘中下跌6.87%，IPO后持续回调新股热度加速消退","url":"https://stock-news.laohu8.com/highlight/detail?id=1164371949","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164371949?lang=zh_cn&edition=full","pubTime":"2026-05-26 09:45","pubTimestamp":1779759936,"startTime":"0","endTime":"0","summary":"5月26日，剂泰科技-P盘中下跌6.87%，报14.87港元，成交额2260.59万港元。该股自5月13日上市首日大涨173%后已连续多个交易日回调，较首日高点回撤显著。消息面上，剂泰科技作为全球AI药物递送第一股于5月13日登陆港交所，IPO发售价10.50港元。公司尚处于商业化早期阶段，过去三年累计亏损约15亿元人民币，营收波动较大，业绩增长前景仍需时间验证。此外，部分国际配售股份未设置禁售期，上市后持续面临获利了结压力。随着新股上市初期市场热度加速消退，股价承压回落态势延续。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141511499","title":"异动解读 | 剂泰科技-P盘中大跌6.56%，IPO后持续回调新股热度加速消退","url":"https://stock-news.laohu8.com/highlight/detail?id=1141511499","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141511499?lang=zh_cn&edition=full","pubTime":"2026-05-21 14:46","pubTimestamp":1779346009,"startTime":"0","endTime":"0","summary":"剂泰科技-P今日盘中大跌6.56%，引发了市场关注。消息面上，该股自上市以来持续面临回调压力。作为全球AI药物递送第一股，公司目前仍处于商业化早期阶段，过去三年累计亏损较大且营收波动，其长期业绩增长前景尚需时间验证，这影响了投资者的短期信心。此外，部分国际配售股份未设置禁售期，导致上市后持续面临获利了结压力。随着新股上市初期的市场热度加速消退，股价的承压回落态势得以延续。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154081201","title":"异动解读｜剂泰科技-P盘中下跌6.56%，IPO后持续回调新股热度加速消退","url":"https://stock-news.laohu8.com/highlight/detail?id=1154081201","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154081201?lang=zh_cn&edition=full","pubTime":"2026-05-21 14:45","pubTimestamp":1779345928,"startTime":"0","endTime":"0","summary":"5月21日，剂泰科技-P盘中下跌6.56%，报16.82港元，成交额9141.32万港元。该股自5月13日上市首日大涨173%后已连续多个交易日回调，较首日高点回撤显著。消息面上，剂泰科技作为全球AI药物递送第一股于5月13日登陆港交所，IPO发售价10.50港元。公司尚处于商业化早期阶段，过去三年累计亏损约15亿元人民币，营收波动较大，业绩增长前景仍需时间验证。此外，部分国际配售股份未设置禁售期，上市后持续面临获利了结压力。随着新股上市初期市场热度加速消退，股价承压回落态势延续。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141184724","title":"异动解读｜剂泰科技-P盘中下跌6.73%，IPO后持续回调新股热度加速消退","url":"https://stock-news.laohu8.com/highlight/detail?id=1141184724","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141184724?lang=zh_cn&edition=full","pubTime":"2026-05-20 09:40","pubTimestamp":1779241257,"startTime":"0","endTime":"0","summary":"5月20日，剂泰科技-P盘中下跌6.73%，报18.9港元，成交额1506.71万港元。该股自5月13日上市首日大涨173%后已连续多日回调，较首日高点回撤明显。消息面上，剂泰科技作为全球AI药物递送第一股于5月13日登陆港交所，IPO发售价10.50港元。公司尚处于商业化早期阶段，过去三年累计亏损约15亿元人民币，营收波动较大，业绩增长前景仍需时间验证。此外，部分国际配售股份未设置禁售期，上市后存在持续的获利了结压力。随着新股上市初期市场热度加速消退，股价承压回落态势延续。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188442804","title":"异动解读 | 剂泰科技-P盘中大跌5.48%，IPO后持续回调新股热度消退","url":"https://stock-news.laohu8.com/highlight/detail?id=1188442804","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188442804?lang=zh_cn&edition=full","pubTime":"2026-05-19 09:54","pubTimestamp":1779155647,"startTime":"0","endTime":"0","summary":"剂泰科技-P今日盘中股价大跌5.48%，引发了市场的关注。消息面上，剂泰科技作为全球AI药物递送第一股，近期刚刚完成首次公开募股并上市。然而，公司在上市首日经历大幅上涨后，股价正进入持续回调阶段。这主要由于公司尚处于商业化的早期阶段，过去三年累计亏损约15亿元人民币，营收表现波动，其未来的业绩增长潜力仍需时间来验证。此外，部分国际配售的股份在上市后并未设置禁售期，这导致了潜在的获利了结压力。随着新股上市初期的市场热度逐渐消退，股价面临的下行压力也随之显现。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636049383","title":"港股剂泰科技-P午前涨超4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636049383","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636049383?lang=zh_cn&edition=full","pubTime":"2026-05-18 11:56","pubTimestamp":1779076619,"startTime":"0","endTime":"0","summary":"5月18日，剂泰科技-P(07666.HK)午前涨超4%，截至发稿，涨3.5%，报22.46港元，成交额6295.67万港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605183740200963.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605183740200963.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4588","BK4585","07666","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636459100","title":"剂泰科技(07666)OpenCGT平台累计合作额超60亿 最新联手沙砾生物达成免疫靶向递送技术合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2636459100","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636459100?lang=zh_cn&edition=full","pubTime":"2026-05-18 10:59","pubTimestamp":1779073183,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，剂泰科技今日宣布，与肿瘤免疫细胞治疗企业沙砾生物正式签署全面技术合作战略协议，双方将围绕免疫靶向脂质纳米颗粒递送技术展开合作，共同推进新一代体内免疫治疗产品的研发与转化。此次合作依托剂泰科技自研的全球首个AI纳米递送平台NanoForge，是该平台赋能OpenCGT项目的又一重要里程碑。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1442760.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1125108383","title":"异动解读 | 剂泰科技-P盘中大跌7.1%，新股热度消退叠加基本面担忧","url":"https://stock-news.laohu8.com/highlight/detail?id=1125108383","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125108383?lang=zh_cn&edition=full","pubTime":"2026-05-18 09:40","pubTimestamp":1779068418,"startTime":"0","endTime":"0","summary":"剂泰科技-P今日盘中股价大幅下挫，跌幅达到7.10%，市场表现引人关注。消息面上，剂泰科技作为全球AI药物递送第一股，于近期登陆港交所，上市首日曾录得显著涨幅。然而，新股热度正逐渐消退，股价自高点持续回调。公司目前仍处于商业化早期阶段，过去三年累计亏损约15亿元，营收表现波动，未来业绩增长前景尚需时间验证。此外，有市场分析指出，该股部分国际配售股份未设置禁售期，上市后存在一定的获利了结压力，这也是导致股价承压回落的重要因素之一。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147331990","title":"异动解读 | 剂泰科技上市次日盘中大涨5.04%，AI药物递送第一股受热捧","url":"https://stock-news.laohu8.com/highlight/detail?id=1147331990","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147331990?lang=zh_cn&edition=full","pubTime":"2026-05-14 09:39","pubTimestamp":1778722773,"startTime":"0","endTime":"0","summary":"剂泰科技-P今日盘中大涨5.04%，延续了其上市首日的强劲表现。消息面上，剂泰科技于昨日正式在港交所挂牌上市，成为“全球AI药物递送第一股”及“港股AI大分子生物制药第一股”。剂泰科技的核心竞争力源于其自主研发的全球首个AI驱动纳米递送平台NanoForge，并基于此开发了多条产品管线。其中，核心产品MTS-004是中国首款完成III期临床的AI赋能制剂新药。这些积极的上市因素和公司基本面增强了市场信心，推动了股价的上涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635227610","title":"剂泰科技-P首挂上市 早盘上涨175.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635227610","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635227610?lang=zh_cn&edition=full","pubTime":"2026-05-13 09:36","pubTimestamp":1778636160,"startTime":"0","endTime":"0","summary":"　　剂泰科技-P首挂上市，公告显示，每股定价10.5港元，共发行2.01亿股股份，每手500股，所得款项净额约为19.93亿港元。截至发稿，股价上涨175.05%，现报28.88港元，成交额13.90亿港元。　　招股书显示，剂泰科技是一家AI纳米材料创新企业，致力于有效载荷在不同生命体中的递送与应用。　　管线方面，剂泰科技已布局超过10款产品，覆盖中枢神经、肿瘤、免疫、代谢等方向。其中，MTS-004为公司进展较快的候选产品。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"51ca393b3c296873b170f3aacad1c881","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggipo/2026-05-13/doc-inhxteir7736326.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["07666","IPOS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.metistechbio.com","stockEarnings":[{"period":"1week","weight":-0.0406},{"period":"1month","weight":0.6448},{"period":"ytd","weight":0.6448}],"compareEarnings":[{"period":"1week","weight":-0.0126},{"period":"1month","weight":-0.023},{"period":"3month","weight":-0.0399},{"period":"6month","weight":-0.0205},{"period":"1year","weight":0.0832},{"period":"ytd","weight":-0.0118}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"AI纳米递送,开启健康未来。剂泰科技是一家人工智能(AI)驱动纳米材料创新的生物科技公司,专注于利用靶向药物递送和发现技术,加速患者在重要疾病领域获得创新疗法。\n公司由美国工程院院士陈红敏博士以及MIT科学家赖才达博士、王文首博士联合创立,成功自主开发了AI纳米基座大模型及三大核心解决方案:AiLNP(AI纳米递送系统设计平台)、AiRNA(AI mRNA序列设计平台)、AiTEM(AI小分子制剂设计平台)。\n公司已具备实现肝脏、肺部、肌肉和免疫细胞等关键组织和细胞的LNP精准靶向递送能力,在多器官、多组织靶向递送难题上取得突破性进展,为肿瘤、代谢系统疾病、自体免疫性疾病、神经系统退行性疾病等提供成药机会。","exchange":"SEHK","name":"剂泰科技-P","nameEN":"METIS TECHBIO-P"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"剂泰科技-P(07666)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供剂泰科技-P(07666)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"剂泰科技-P,07666,剂泰科技-P股票,剂泰科技-P股票老虎,剂泰科技-P股票老虎国际,剂泰科技-P行情,剂泰科技-P股票行情,剂泰科技-P股价,剂泰科技-P股市,剂泰科技-P股票价格,剂泰科技-P股票交易,剂泰科技-P股票购买,剂泰科技-P股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"剂泰科技-P(07666)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供剂泰科技-P(07666)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}